A publicly owned pharmaceutical industry is the best solution to stopping drug shortages.
by Dana Brown and Christopher Morten, Stat
Drug shortages in the United States are at a record high. At least 14 essential generic cancer drugs are currently in shortage, forcing patients and doctors to make difficult decisions to delay or ration first-line treatments, or accept second-best treatments. ADHD treatments, antibiotics, children’s acetaminophen, and many other critical medicines are also in short supply.
But most of the solutions being discussed are just Band-Aids on a broken system. They would do nothing to transform the incentives that routinely produce shortages and other market failures.

What we really need — for the health of our economy and society — is a robust public option in pharmaceuticals that produces and distributes essential medicines, such as cancer treatments. Publicly accountable public agencies can assure resilient supply chains and offer medicines at or even below cost, because keeping people healthy without bankrupting them in the process is good for society (and cost-effective to boot). This already happens at scales large and small all over the world, including Brazil, Sweden, Cuba, the U.K., India, Thailand, and more.
Recent Posts
Bad Bunny Destroys MAGA Backlash During SNL: “If You Don’t Understand Me, You Have Four Months To Learn”
October 19, 2025
Take Action Now “All Latinos and Latinas all over the world, and here in the United States, all the people who have worked to open doors. More than…
Senators Launch Bipartisan Bid to Block Trump War on Venezuela
October 18, 2025
Take Action Now “Congress has not authorized military force against Venezuela,” said Sen. Adam Schiff. “And we must assert our authority to stop the…
Democrats Have Let Republicans Become The “Peace” Party
October 17, 2025
Take Action Now The massive disconnect between the Democratic Party’s leadership and its base is sure to have ramifications far beyond last year’s…
‘Textbook Authoritarianism’: Trump Aims IRS Criminal Division At Left-Leaning Groups, Donors
October 16, 2025
Take Action Now Reporting by the Wall Street Journal indicates the active “weaponization” of the agency to target the far-right president’s political…